Sponsor:
Mount Sinai Hospital, Canada
Code:
NCT02999724
Conditions
Pelvic Organ Prolapse
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Gabapentin
placebo
Brief summary:
Conditions
Pelvic Organ Prolapse
Study ID
NCT02999724
Start date
Jan, 2017
Status verified date
Feb, 2017
Completion date
Jan, 2018
Anticipated
Primary completion date
Sep, 2017
Anticipated
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
44 participants
Anticipated
Allocation
Randomized
Intervention Model
Single group
Primary purpose
Treatment
Arms
experimental: gabapentin
placebo comparator: placebo
Interventions
Gabapentin
placebo
Primary outcome measure
Central contacts
Locations
Department of Obstetrics and Gynecology, Mount Sinai Hospital
Recruiting
Toronto, Ontario, Canada, M5G1Z5
Contacts
Principal Investigator:
Danny Lovatsis, MD MSc
Sponsor
Mount Sinai Hospital, Canada
Last update posted
Feb 14, 2017
Last verified
Feb, 2017
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Mount Sinai Hospital, Canada on 2017-02-14.